LYCA SEC Filings, Earnings & Splits

Venrock-affiliated filer Nimish P. Shah executed a power of attorney authorizing designated attorneys-in-fact to prepare and file Schedule 13D/13G and Section 16 filings on his behalf. This is an administrative exhibit to a Schedule 13G filing and does not reflect a change in beneficial ownership.

Lycia Therapeutics filed an Amended and Restated Certificate of Incorporation, authorizing 510,000,000 total shares consisting of 500,000,000 shares of Common Stock and 10,000,000 shares of Preferred Stock, and adopting governance provisions including board authority over bylaws and supermajority stockholder voting requirements.

Lycia Therapeutics, Inc. filed an EFFECT notice with the SEC, indicating that a registration statement has been declared effective.